Comments
Loading...
Labcorp Hldgs Stock Guidance | NYSE:LH | Benzinga
Labcorp Hldgs issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/29/2025 | LH | Labcorp Hldgs | FY | 2025 | $15.70 | $16.40 | $16.05 | $13.98B | $14.15B | $13.92B | Get Alert |
| 02/06/2025 | LH | Labcorp Holdings | FY | 2025 | $15.60 | $16.40 | $15.99 | $13.88B | $14.05B | $13.77B | Get Alert |
| 10/24/2024 | LH | Labcorp Holdings | FY | 2024 | $14.30 | $14.70 | $14.56 | $12.96B | $13.05B | $12.96B | Get Alert |
| 08/01/2024 | LH | Labcorp Holdings | FY | 2024 | $14.30 | $14.90 | $14.82 | $12.94B | $13.07B | $12.83B | Get Alert |
| 06/04/2024 | LH | Labcorp Holdings | FY | 2024 | $14.45 | $15.35 | $14.83 | $12.89B | $12.89B | $12.83B | Get Alert |
| 04/25/2024 | LH | Laboratory Corp | FY | 2024 | $14.45 | $15.35 | $14.82 | $12.75B | $12.94B | $12.76B | Get Alert |
| 02/15/2024 | LH | Laboratory Corp | FY | 2024 | $14.30 | $15.40 | $14.60 | $12.73B | $12.95B | $12.58B | Get Alert |
| 10/26/2023 | LH | Laboratory Corp | FY | 2023 | $13.25 | $13.75 | $13.63 | $12.13B | $12.22B | $12.09B | Get Alert |
| 09/14/2023 | LH | Laboratory Corp | FY | 2023 | $13.00 | $14.00 | $13.66 | $12.08B | $12.26B | $12.16B | Get Alert |
| 09/14/2023 | LH | Laboratory Corp | FY | 2026 | — | — | — | $14.00B | — | — | Get Alert |
| 07/27/2023 | LH | Laboratory Corp | FY | 2023 | $13.00 | $14.00 | $14.02 | $12.08B | $12.26B | $12.63B | Get Alert |
| 04/25/2023 | LH | Laboratory Corp | FY | 2023 | $16.25 | $17.75 | $17.17 | — | — | — | Get Alert |
| 02/16/2023 | LH | Laboratory Corp | FY | 2023 | $16.00 | $18.00 | $17.65 | $15.03B | $15.47B | $15.01B | Get Alert |
| 10/27/2022 | LH | Laboratory Corp | FY | 2022 | $19.25 | $20.25 | $20.19 | $14.91B | $15.15B | $15.19B | Get Alert |
| 07/28/2022 | LH | Laboratory Corp | FY | 2022 | $19.00 | $21.25 | $19.70 | $15.15B | $15.80B | $15.31B | Get Alert |
| 04/28/2022 | LH | Laboratory Corp | FY | 2022 | $18.25 | $21.00 | $19.54 | $15.23B | $15.88B | $15.38B | Get Alert |
| 02/10/2022 | LH | Laboratory Corp | FY | 2022 | $17.25 | $21.25 | $18.03 | $15.07B | $15.88B | $14.67B | Get Alert |
| 10/28/2021 | LH | Laboratory Corp | FY | 2021 | $26.00 | $28.00 | $24.16 | $15.80B | $15.94B | $15.22B | Get Alert |
| 07/29/2021 | LH | Laboratory Corp | FY | 2021 | $21.50 | $25.00 | $22.54 | $14.89B | $15.24B | $14.56B | Get Alert |
| 04/29/2021 | LH | Laboratory Corp | FY | 2021 | $20.00 | $24.00 | $21.32 | $14.26B | $14.89B | $14.25B | Get Alert |
| 02/11/2021 | LH | Laboratory Corp | FY | 2021 | $19.00 | $23.00 | $20.14 | $13.84B | $14.61B | $14.15B | Get Alert |
FAQ
What is the most recent guidance for Labcorp Hldgs (LH)?
The most recent guidance for Labcorp Hldgs (LH) was reported on April 29, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $15.70 to $16.40, compared to the estimated EPS of $16.05. Additionally, Labcorp Hldgs forecasted revenue between $13.98B and $14.15B for the quarter.
Browse guidance and forecast on all stocks.
